Stock Screener · Library
Allogene Therapeutics, Inc. financial statement history
Source-linked financial facts for Allogene Therapeutics, Inc. with exact reported periods, units and filing dates. Historical periods ending 2021–2025.
What this record covers
This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.
Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.
Total assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 1050828000 | USD | 2024-03-14 | 2022 / FY | us-gaap:Assets | 10-K/A · 0001737287-24-000018 |
| As of 2022-03-31 | 978091000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Assets | 10-K · 0001737287-24-000021 |
| As of 2022-06-30 | 955621000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Assets | 10-K · 0001737287-24-000021 |
| As of 2022-09-30 | 894477000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Assets | 10-K · 0001737287-24-000021 |
| As of 2022-12-31 | 821579000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Assets | 10-K · 0001737287-24-000021 |
| As of 2023-03-31 | 750128000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Assets | 10-K · 0001737287-24-000021 |
| As of 2023-06-30 | 773007000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Assets | 10-K · 0001737287-24-000021 |
| As of 2023-09-30 | 713411000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Assets | 10-K · 0001737287-24-000021 |
| As of 2023-12-31 | 642837000 | USD | 2025-03-13 | 2024 / FY | us-gaap:Assets | 10-K · 0001737287-25-000036 |
| As of 2024-12-31 | 548710000 | USD | 2026-03-12 | 2025 / FY | us-gaap:Assets | 10-K · 0001628280-26-017242 |
| As of 2025-12-31 | 415905000 | USD | 2026-03-12 | 2025 / FY | us-gaap:Assets | 10-K · 0001628280-26-017242 |
Current assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 471323000 | USD | 2024-03-14 | 2022 / FY | us-gaap:AssetsCurrent | 10-K/A · 0001737287-24-000018 |
| As of 2022-03-31 | 469744000 | USD | 2024-03-14 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0001737287-24-000021 |
| As of 2022-06-30 | 513028000 | USD | 2024-03-14 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0001737287-24-000021 |
| As of 2022-09-30 | 569061000 | USD | 2024-03-14 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0001737287-24-000021 |
| As of 2022-12-31 | 528824000 | USD | 2024-03-14 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0001737287-24-000021 |
| As of 2023-03-31 | 481465000 | USD | 2024-03-14 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0001737287-24-000021 |
| As of 2023-06-30 | 502101000 | USD | 2024-03-14 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0001737287-24-000021 |
| As of 2023-09-30 | 473454000 | USD | 2024-03-14 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0001737287-24-000021 |
| As of 2023-12-31 | 459115000 | USD | 2025-03-13 | 2024 / FY | us-gaap:AssetsCurrent | 10-K · 0001737287-25-000036 |
| As of 2024-12-31 | 303386000 | USD | 2026-03-12 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001628280-26-017242 |
| As of 2025-12-31 | 257749000 | USD | 2026-03-12 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001628280-26-017242 |
Cash and cash equivalents
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 173314000 | USD | 2024-03-14 | 2022 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K/A · 0001737287-24-000018 |
| As of 2022-03-31 | 84514000 | USD | 2024-03-14 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001737287-24-000021 |
| As of 2022-06-30 | 96041000 | USD | 2024-03-14 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001737287-24-000021 |
| As of 2022-09-30 | 74357000 | USD | 2024-03-14 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001737287-24-000021 |
| As of 2022-12-31 | 61904000 | USD | 2024-03-14 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001737287-24-000021 |
| As of 2023-03-31 | 109931000 | USD | 2024-03-14 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001737287-24-000021 |
| As of 2023-06-30 | 154758000 | USD | 2024-03-14 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001737287-24-000021 |
| As of 2023-09-30 | 69246000 | USD | 2024-03-14 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001737287-24-000021 |
| As of 2023-12-31 | 83155000 | USD | 2025-03-13 | 2024 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001737287-25-000036 |
| As of 2024-12-31 | 75218000 | USD | 2026-03-12 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001628280-26-017242 |
| As of 2025-12-31 | 51688000 | USD | 2026-03-12 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001628280-26-017242 |
Property, plant and equipment
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 122990000 | USD | 2024-03-14 | 2022 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K/A · 0001737287-24-000018 |
| As of 2022-03-31 | 120200000 | USD | 2024-03-14 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001737287-24-000021 |
| As of 2022-06-30 | 117216000 | USD | 2024-03-14 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001737287-24-000021 |
| As of 2022-09-30 | 114442000 | USD | 2024-03-14 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001737287-24-000021 |
| As of 2022-12-31 | 112839000 | USD | 2024-03-14 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001737287-24-000021 |
| As of 2023-03-31 | 109849000 | USD | 2024-03-14 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001737287-24-000021 |
| As of 2023-06-30 | 106386000 | USD | 2024-03-14 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001737287-24-000021 |
| As of 2023-09-30 | 102826000 | USD | 2024-03-14 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001737287-24-000021 |
| As of 2023-12-31 | 99478000 | USD | 2025-03-13 | 2024 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001737287-25-000036 |
| As of 2024-12-31 | 86056000 | USD | 2026-03-12 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001628280-26-017242 |
| As of 2025-12-31 | 72839000 | USD | 2026-03-12 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001628280-26-017242 |
Total liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 125628000 | USD | 2024-03-14 | 2022 / FY | us-gaap:Liabilities | 10-K/A · 0001737287-24-000018 |
| As of 2022-03-31 | 112823000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Liabilities | 10-K · 0001737287-24-000021 |
| As of 2022-06-30 | 149138000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Liabilities | 10-K · 0001737287-24-000021 |
| As of 2022-09-30 | 151076000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Liabilities | 10-K · 0001737287-24-000021 |
| As of 2022-12-31 | 154697000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Liabilities | 10-K · 0001737287-24-000021 |
| As of 2023-03-31 | 158118000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Liabilities | 10-K · 0001737287-24-000021 |
| As of 2023-06-30 | 151596000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Liabilities | 10-K · 0001737287-24-000021 |
| As of 2023-09-30 | 132776000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Liabilities | 10-K · 0001737287-24-000021 |
| As of 2023-12-31 | 130604000 | USD | 2025-03-13 | 2024 / FY | us-gaap:Liabilities | 10-K · 0001737287-25-000036 |
| As of 2024-12-31 | 126531000 | USD | 2026-03-12 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001628280-26-017242 |
| As of 2025-12-31 | 123363000 | USD | 2026-03-12 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001628280-26-017242 |
Current liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 47907000 | USD | 2024-03-14 | 2022 / FY | us-gaap:LiabilitiesCurrent | 10-K/A · 0001737287-24-000018 |
| As of 2022-03-31 | 36618000 | USD | 2024-03-14 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001737287-24-000021 |
| As of 2022-06-30 | 44177000 | USD | 2024-03-14 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001737287-24-000021 |
| As of 2022-09-30 | 48082000 | USD | 2024-03-14 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001737287-24-000021 |
| As of 2022-12-31 | 53728000 | USD | 2024-03-14 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001737287-24-000021 |
| As of 2023-03-31 | 59398000 | USD | 2024-03-14 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001737287-24-000021 |
| As of 2023-06-30 | 54578000 | USD | 2024-03-14 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001737287-24-000021 |
| As of 2023-09-30 | 37486000 | USD | 2024-03-14 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001737287-24-000021 |
| As of 2023-12-31 | 37079000 | USD | 2025-03-13 | 2024 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001737287-25-000036 |
| As of 2024-12-31 | 35523000 | USD | 2026-03-12 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001628280-26-017242 |
| As of 2025-12-31 | 32514000 | USD | 2026-03-12 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001628280-26-017242 |
Stockholders equity
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 925200000 | USD | 2024-03-14 | 2023 / FY | us-gaap:StockholdersEquity | 10-K · 0001737287-24-000021 |
| As of 2022-03-31 | 865267000 | USD | 2024-03-14 | 2023 / FY | us-gaap:StockholdersEquity | 10-K · 0001737287-24-000021 |
| As of 2022-06-30 | 806483000 | USD | 2024-03-14 | 2023 / FY | us-gaap:StockholdersEquity | 10-K · 0001737287-24-000021 |
| As of 2022-09-30 | 743401000 | USD | 2024-03-14 | 2023 / FY | us-gaap:StockholdersEquity | 10-K · 0001737287-24-000021 |
| As of 2022-12-31 | 666882000 | USD | 2025-03-13 | 2024 / FY | us-gaap:StockholdersEquity | 10-K · 0001737287-25-000036 |
| As of 2023-03-31 | 592010000 | USD | 2024-03-14 | 2023 / FY | us-gaap:StockholdersEquity | 10-K · 0001737287-24-000021 |
| As of 2023-06-30 | 621411000 | USD | 2024-03-14 | 2023 / FY | us-gaap:StockholdersEquity | 10-K · 0001737287-24-000021 |
| As of 2023-09-30 | 580635000 | USD | 2024-03-14 | 2023 / FY | us-gaap:StockholdersEquity | 10-K · 0001737287-24-000021 |
| As of 2023-12-31 | 512233000 | USD | 2026-03-12 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001628280-26-017242 |
| As of 2024-12-31 | 422179000 | USD | 2026-03-12 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001628280-26-017242 |
| As of 2025-12-31 | 292542000 | USD | 2026-03-12 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001628280-26-017242 |
Revenue
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 114089000 | USD | 2024-03-14 | 2023 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001737287-24-000021 |
| 2022-01-01 to 2022-12-31 | 156000 | USD | 2024-03-14 | 2023 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001737287-24-000021 |
| 2023-01-01 to 2023-12-31 | 95000 | USD | 2025-03-13 | 2024 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001737287-25-000036 |
| 2024-01-01 to 2024-12-31 | 22000 | USD | 2026-03-12 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001628280-26-017242 |
| 2025-01-01 to 2025-12-31 | 0 | USD | 2026-03-12 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001628280-26-017242 |
Research and development
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 220176000 | USD | 2024-03-14 | 2023 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001737287-24-000021 |
| 2022-01-01 to 2022-12-31 | 256387000 | USD | 2024-03-14 | 2023 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001737287-24-000021 |
| 2023-01-01 to 2023-12-31 | 242914000 | USD | 2025-03-13 | 2024 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001737287-25-000036 |
| 2024-01-01 to 2024-12-31 | 192299000 | USD | 2026-03-12 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001628280-26-017242 |
| 2025-01-01 to 2025-12-31 | 150152000 | USD | 2026-03-12 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001628280-26-017242 |
Operating income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -180192000 | USD | 2024-03-14 | 2023 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001737287-24-000021 |
| 2022-01-01 to 2022-12-31 | -335536000 | USD | 2024-03-14 | 2023 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001737287-24-000021 |
| 2023-01-01 to 2023-12-31 | -327737000 | USD | 2025-03-13 | 2024 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001737287-25-000036 |
| 2024-01-01 to 2024-12-31 | -273199000 | USD | 2026-03-12 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001628280-26-017242 |
| 2025-01-01 to 2025-12-31 | -209315000 | USD | 2026-03-12 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001628280-26-017242 |
Net income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -182051000 | USD | 2024-03-14 | 2023 / FY | us-gaap:NetIncomeLoss | 10-K · 0001737287-24-000021 |
| 2022-01-01 to 2022-12-31 | -340414000 | USD | 2024-03-14 | 2023 / FY | us-gaap:NetIncomeLoss | 10-K · 0001737287-24-000021 |
| 2023-01-01 to 2023-12-31 | -327265000 | USD | 2025-03-13 | 2024 / FY | us-gaap:NetIncomeLoss | 10-K · 0001737287-25-000036 |
| 2024-01-01 to 2024-12-31 | -257590000 | USD | 2026-03-12 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001628280-26-017242 |
| 2025-01-01 to 2025-12-31 | -190886000 | USD | 2026-03-12 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001628280-26-017242 |
Diluted earnings per share
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -1.34 | USD/shares | 2024-03-14 | 2023 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001737287-24-000021 |
| 2022-01-01 to 2022-12-31 | -2.38 | USD/shares | 2024-03-14 | 2023 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001737287-24-000021 |
| 2023-01-01 to 2023-12-31 | -2.09 | USD/shares | 2025-03-13 | 2024 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001737287-25-000036 |
| 2024-01-01 to 2024-12-31 | -1.32 | USD/shares | 2026-03-12 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001628280-26-017242 |
| 2025-01-01 to 2025-12-31 | -0.87 | USD/shares | 2026-03-12 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001628280-26-017242 |
Operating cash flow
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -184812000 | USD | 2024-03-14 | 2023 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001737287-24-000021 |
| 2022-01-01 to 2022-12-31 | -220519000 | USD | 2024-03-14 | 2023 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001737287-24-000021 |
| 2023-01-01 to 2023-12-31 | -237733000 | USD | 2025-03-13 | 2024 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001737287-25-000036 |
| 2024-01-01 to 2024-12-31 | -200300000 | USD | 2026-03-12 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001628280-26-017242 |
| 2025-01-01 to 2025-12-31 | -149246000 | USD | 2026-03-12 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001628280-26-017242 |
Capital expenditure
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 21446000 | USD | 2024-03-14 | 2023 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001737287-24-000021 |
| 2022-01-01 to 2022-12-31 | 5191000 | USD | 2024-03-14 | 2023 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001737287-24-000021 |
| 2023-01-01 to 2023-12-31 | 1516000 | USD | 2025-03-13 | 2024 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001737287-25-000036 |
| 2024-01-01 to 2024-12-31 | 694000 | USD | 2026-03-12 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001628280-26-017242 |
| 2025-01-01 to 2025-12-31 | 386000 | USD | 2026-03-12 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001628280-26-017242 |
Source and method
SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.
The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.
- Source filer CIK
- 1737287
- Ticker in native snapshot
- ALLO
- Reported numeric facts
- 112
- Units present
- USD · USD/shares